Future FinTech Group Expands into Biomedical Sector with TransGen Acquisition

Future FinTech Expands into Biomedical Sector with Strategic Acquisition

Future FinTech Group, a leading provider of financial and digital technology services, announces a significant move to diversify its portfolio by acquiring TransGen SC Tech Limited. This strategic acquisition, facilitated through its subsidiary Future FinTech (Hong Kong) Limited, marks a pivotal step for the company, aiming to enhance its presence in the health and wellness sector. The Framework Agreement signed on January 7, 2026, outlines the intention to acquire 100% of TransGen, with the acquisition process expected to be completed within 90 days, contingent upon satisfactory due diligence and financial audits.

TransGen is recognized for its innovative research and development in biofactors, particularly in creating treatments for prevalent health issues like diabetes and Alzheimer's disease. The company’s expertise extends to the exploration of microalgal extracellular vesicles, which hold promise for drug delivery and diagnostic applications. With a portfolio of 26 invention and utility model patents, TransGen stands out in the biomedical field, underpinned by certifications such as the Level 2 Biosafety Laboratory Certification. These credentials not only affirm the company's compliance with health and safety standards but also demonstrate its commitment to establishing industry benchmarks in stem cell processing.

The acquisition resonates with Future FinTech's strategic vision of integrating advanced technological solutions across various industries, particularly health and wellness. Gai Wei, Director of TransGen, expresses optimism about the partnership, highlighting the potential for enhanced international expansion and technological advancement. By leveraging Future FinTech's global resources, TransGen aims to broaden its market reach and amplify its impact on human health through innovative biological technologies. This collaboration signifies an important intersection of technology and healthcare, positioning both companies to capitalize on emerging opportunities within the biomedical landscape.

In addition to the acquisition, Future FinTech continues to focus on expanding its technological capabilities. This move aligns with the growing trend of cross-sector partnerships that blend technology with healthcare solutions, reflecting a broader industry shift towards innovation-driven approaches. As Future FinTech navigates this new terrain, its commitment to enhancing health outcomes through technology remains a central tenet of its corporate strategy.

The partnership with TransGen not only enhances Future FinTech's service offerings but also underscores its dedication to improving quality of life through advanced biological technologies. As the acquisition process unfolds, the industry watches closely to see how this collaboration will shape the future of healthcare innovations.